Products
2681 products
Code | Description | Unit |
---|---|---|
EPO0146000 | Olsalazine sodium | EP unit |
EPO0146010 | Olsalazine sodium for performance test | EP unit |
EPO0150000 | Omeprazole | EP unit |
EPY0001042 | Omeprazole for peak identification | EP unit |
EPO0151000 | Omeprazole impurity D - Omeprazole sulphone | EP unit |
EPY0001043 | Omeprazole magnesium | EP unit |
EPY0000197 | Ondansetron for LC system suitability | EP unit |
EPY0000196 | Ondansetron for TLC system suitability | EP unit |
EPY0000218 | Ondansetron hydrochloride dihydrate | EP unit |
EPY0001345 | Ondansetron impurity A - (3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9- tetrahydro-4H-carbazol-4-one | EP unit |
EPY0000195 | Ondansetron impurity D - 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one | EP unit |
EPY0001326 | Ondansetron impurity E - Imidazole | EP unit |
EPY0001320 | Ondansetron impurity F | EP unit |
EPY0001346 | Ondansetron impurity G - (3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one (C-demethylondansetron) | EP unit |
EPY0001125 | Orbifloxacin | EP unit |
EPY0001147 | Orbifloxacin impurity mixture | EP unit |
EPY0000895 | Orciprenaline for system suitability | EP unit |
EPO0180000 | Orciprenaline sulphate | EP unit |
EPY0001501 | Orientvine stem HRS | EP unit |
EPY0000101 | Orphenadrine citrate | EP unit |
EPY0001181 | Orphenadrine for peak identification | EP unit |
EPY0000100 | Orphenadrine hydrochloride | EP unit |
EPY0000102 | Orphenadrine impurity E - (RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy]ethanamine (meta-methylbenzyl isomer) | EP unit |
EPY0001338 | Oseltamivir impurity A - (3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid | EP unit |
EPY0001339 | Oseltamivir impurity B - ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3- (1-ethylpropoxy)cyclohexanecarboxylate | EP unit |
EPY0001340 | Oseltamivir impurity C - (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid | EP unit |
EPY0001341 | Oseltamivir impurity H - tributylphosphane oxide | EP unit |
EPY0001337 | Oseltamivir phosphate impurity B - free | EP unit |
EPY0001207 | Osthole | EP unit |
EPO0200000 | Ouabain | EP unit |
EPY0000560 | Oxacillin for peak identification | EP unit |
EPY0000638 | Oxacillin sodium monohydrate | EP unit |
EPY0000271 | Oxaliplatin | EP unit |
EPY0000272 | Oxaliplatin impurity B - (SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2-diamine-kN,kN']platinum (diaquodiaminocyclohexaneplatinum) | EP unit |
EPY0000273 | Oxaliplatin impurity C - (OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)- kO¹,kO²]dihydroxyplatinum | EP unit |
EPY0000274 | Oxaliplatin impurity D - (SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethane- dioato(2-)-kO1,kO2]platinum (S,S-enantiomer of oxaliplatin) | EP unit |
EPY0000543 | Oxazepam for peak identification | EP unit |
EPY0001576 | Oxcarbazepine | EP unit |
EPY0001549 | Oxcarbazepine impurity mixture | EP unit |
EPY0000350 | Oxeladin hydrogen citrate | EP unit |
EPY0000404 | Oxeladin impurity C - 2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate | EP unit |
EPY0000390 | Oxeladin impurity D - 2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate | EP unit |
EPO0225800 | Oxfendazole for veterinary use | EP unit |
EPY0000224 | Oxfendazole impurity B - methyl[5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate | EP unit |
EPY0000225 | Oxfendazole with impurity D | EP unit |
EPO0260000 | Oxibendazole | EP unit |
EPY0000709 | Oxitropium bromide | EP unit |
EPY0000715 | Oxitropium bromide impurity B - (1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine) | EP unit |
EPY0000713 | Oxitropium bromide impurity D - (1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine) | EP unit |
EPO0240000 | Oxolinic acid | EP unit |
EPO0240005 | Oxolinic acid impurity A - 8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid | EP unit |
EPO0240010 | Oxolinic acid impurity B - ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7-carboxylate | EP unit |
EPO0250000 | Oxprenolol hydrochloride | EP unit |
EPO0270000 | Oxybuprocaine hydrochloride | EP unit |
EPO0288000 | Oxybutynin hydrochloride | EP unit |
EPO0288005 | Oxybutynin impurity A - 4-(diethylamino)but-2-ynyl(RS)-2-(cyclohex-3-enyl)-2-cyclohexyl-2-hydroxyacetate | EP unit |
EPY0000453 | Oxycodone impurity D - 7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy-17- methylmorphinan-6-one (14-hydroxycodeinone) | EP unit |
EPO0290000 | Oxymetazoline hydrochloride | EP unit |
EPY0001044 | Oxymetazoline impurity A - N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]acetamide | EP unit |
EPY0001896 | Oxytetracycline | EP-unit |
EPY0001850 | Oxytetracycline for system suitability | EP-unit |
EPO0500000 | Oxytetracycline hydrochloride | EP unit |
EPO0700000 | Oxytocin | EP unit |
EPO0770000 | Oxytocin/Desmopressin validation mixture about 0.1 mg oxytocin + 0.1 mg desmopressin per vial (20 mg) | EP unit |
EPY0000698 | Paclitaxel | EP unit |
EPY0000699 | Paclitaxel impurity C - N-debenzoyl-N-hexanoylpaclitaxel | EP unit |
EPY0000700 | Paclitaxel natural for peak identification | EP unit |
EPY0000719 | Paclitaxel semi-synthetic for peak identification | EP unit |
EPY0000739 | Paclitaxel semi-synthetic for system suitability | EP unit |
EPY0001856 | Paeoniflorin | EP-unit |
EPP0090000 | Palmitic acid | EP unit |
EPY0000524 | Pamidronate disodium pentahydrate | EP unit |
EPP0100000 | Pancreas powder (amylase and lipase) BRP | EP unit |
EPY0001632 | Pancreas powder (amylase) BRP | EP unit |
EPY0001631 | Pancreas powder (lipase) BRP | EP unit |
EPP0200000 | Pancreas powder (protease) BRP | EP unit |
EPY0000577 | Pancuronium bromide for system suitability | EP unit |
EPP0250000 | Pancuronium bromide Vecuronium impurity B - | EP unit |
EPY0001001 | Pantoprazole for system suitability | EP unit |
EPY0000835 | Pantoprazole sodium sesquihydrate | EP unit |
EPP0270000 | Papaverine hydrochloride | EP unit |
EPP0300000 | Paracetamol | EP unit |
EPY0000780 | Paraffin (hard) | EP unit |
EPY0000058 | Paraffin (liquid) - Reference Spectrum | EP unit |
EPY0000913 | Paraffin (White soft) | EP unit |
EPY0000912 | Paraffin (Yellow soft) | EP unit |
EPP0305000 | Parnaparin sodium | EP unit |
EPY0000630 | Paroxetine for system suitability | EP unit |
EPY0000578 | Paroxetine hydrochloride (anhydrous) | EP unit |
EPY0000579 | Paroxetine hydrochloride (anhydrous) impurity C - (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine (N-benzylparoxetine) | EP unit |
EPY0000581 | Paroxetine hydrochloride (anhydrous) impurity H - [(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol | EP unit |
EPY0000281 | Paroxetine hydrochloride hemihydrate | EP unit |
EPY0000233 | Paroxetine impurity A - (3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine (desfluoroparoxetine) | EP unit |
EPY0000256 | Paroxetine impurity D - (3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine ((+)-trans-paroxetine) | EP unit |
EPY0000580 | Paroxetine impurity E - (3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophenyl)piperidine (cis-paroxetine) | EP unit |
EPP0309020 | Pefloxacin impurity B - 1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (chlorinated homologue of pefloxacin) | EP unit |
EPP0309030 | Pefloxacin impurity C - 1-ethyl-6-fluoro-5-(4-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (isopefloxacin) | EP unit |
EPP0309000 | Pefloxacin mesilate dihydrate | EP unit |
EPY0001539 | Pemetrexed disodium heptahydrate | EP unit |
EPY0001538 | Pemetrexed for system suitability | EP unit |